产品展示
A1239 Telomeric Repeat Binding Factor 1 (Phospho-Ser219) Antibody
点击次数：110发布时间：2012/9/7 14:13:44
更新日期：2024/10/16 15:59:55
所 在 地：美洲
产品型号：
优质供应
详细内容
慧嘉生物您实验身边的好伙伴
为客户提供“品质的产品”和“*优质的服务”
AssayBiotech CUSABIO Immunoway Santa Abcam Cst jackson Pierce Sigma Amresco Qiagen Cayman abnova millipore invitrogen ebioscience prospec
欢迎广大客户咨询，另有大量宣传海报和小礼品赠送。
网站：www.biohj.com
联系电话：
传 真：
Q Q：1193953234 1048735792
邮 箱：sale@biohj.com
A1239 Telomeric Repeat Binding Factor 1 （Phospho-Ser219） Antibody
| Reactivity | Applications | MW. | Source |
| H, M | WB ELISA | 50 kDa | Rabbit |
Note: The product is for research use only, not for use in diagnostic or therapeutic procedures.
| Product Name | Telomeric Repeat Binding Factor 1 （Phospho-Ser219） Antibody |
| Synonyms | NIMA-interacting protein 2; PIN2; TERF1; TRF; TTAGGG repeat binding factor 1; Telomeric protein Pin2/TRF1; Telomeric repeat binding factor 1 |
| Immunogen | The antiserum was produced against synthesized peptide derived from human Telomeric Repeat Binding Factor 1 around the phosphorylation site of Ser219. |
| Immunogen Region | Internal |
| Clonality | Polyclonal |
| Modification sites | H:S219 M:S206 |
| Application dilutions | WB: 1:500~1:1000 ELISA: 1:5000 |
| Specificity | Telomeric Repeat Binding Factor 1 （Phospho-Ser219） Antibody detects endogenous levels of Telomeric Repeat Binding Factor 1 only when phosphorylated at serine219. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation. |
| Physical Form | Rabbit IgG in phosphate buffered saline （without Mg2+ ａnd Ca2+）, pH 7.4, 150mM NaCl, 0.02% sodium azide ａnd 50% glycerol. |
| Concentration | 1 mg/ml |
| Storage/Stability | Store at -20℃/1 year |
| NCBI Gene Symbol | TERF1 | ||||||||
| Database Links |
| ||||||||
| Application images |  Western blot analysis of extracts from 293 cells treated with paclitaxel 1uM 24h, using Telomeric Repeat Binding Factor 1 （Phospho-Ser219） Antibody. The lane on the right is treated with the synthesized peptide. |
